Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patients
- 12 March 2013
- journal article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 113 (2), 267-275
- https://doi.org/10.1007/s11060-013-1106-6
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Evidence for potentials and limitations of brain plasticity using an atlas of functional resectability of WHO grade II gliomas: Towards a “minimal common brain”NeuroImage, 2011
- Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in GliomasJournal of Clinical Oncology, 2009
- Lack of complete 1p19q deletion in a consecutive series of 12 WHO grade II gliomas involving the insula: a marker of worse prognosis?Journal of Neuro-Oncology, 2008
- Seizure characteristics and control following resection in 332 patients with low-grade gliomasJournal of Neurosurgery, 2008
- Temozolomide for low-grade gliomasNeurology, 2007
- Dynamic history of low‐grade gliomas before and after temozolomide treatmentAnnals of Neurology, 2007
- Radical surgery after chemotherapy: a new therapeutic strategy to envision in grade II gliomaJournal of Neuro-Oncology, 2006
- Preferential brain locations of low‐grade gliomasCancer, 2004
- Functional mapping-guided resection of low-grade gliomas.1995
- The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomasCancer, 1994